Catechol-O-methyltransferase gene and obsessive–compulsive symptoms in patients with recent-onset schizophrenia: Preliminary results

References 

1. Alsobrook JP, Zohar AH, Leboyer M, Chabane N, Ebstein RP, Pauls DL. Association between the COMT locus and obsessive–compulsive disorder in females but not males. American Journal of Medical Genetics. 2002;1:116–120
2. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Press; 1994;
3. Azzam A, Mathews CA. Meta-analysis of the association between the catecholamine-O-methyl-transferase gene and obsessive–compulsive disorder. American Journal of Medical Genetics. 2003;1:64–69
4. Blier P, Szabo ST. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety. Journal of Clinical Psychiatry. 2005;66(Suppl 8):30–40
5. Byerly M, Goodman W, Acholonu W, Bugno R, Rush AJ. Obsessive compulsive symptoms in schizophrenia: frequency and clinical features. Schizophrenia Research. 2005;2–3:309–316
6. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. American Journal of Human Genetics. 2004;5:807–821
7. de Haan L, Linszen DH, Gorsira R. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. Journal of Clinical Psychiatry. 1999;6:364–365
8. de Haan L, Beuk N, Hoogenboom B, Dingemans P, Linszen D. Obsessive–compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders. Journal of Clinical Psychiatry. 2002;2:104–107
9. de Haan L, Oekeneva A, Van Amelsvoort T, Linszen D. Obsessive–compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders. European Psychiatry. 2004;8:524
10. Denys D, van der WN, Janssen J, de Geus F, Westenberg HG. Low level of dopaminergic D2 receptor binding in obsessive–compulsive disorder. Biological Psychiatry. 2004;10:1041–1045
11. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 2001;12:6917–6922
12. Eley TC, Tahir E, Angleitner A, Harriss K, McClay J, Plomin R, et al. Association analysis of MAOA and COMT with neuroticism assessed by peers. American Journal of Medical Genetics. 2003;1:90–96
13. Erdal ME, Tot S, Yazici K, Yazici A, Herken H, Erdem P, et al. Lack of association of catechol-O-methyltransferase gene polymorphism in obsessive–compulsive disorder. Depression and Anxiety. 2003;1:41–45
14. Fanous AH, Kendler KS. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework. Molecular Psychiatry. 2005;1:6–13
15. Gasparini M, Fabrizio E, Bonifati V, Meco G. Cognitive improvement during Tolcapone treatment in Parkinson's disease. Journal of Neural Transmission. 1997;8–9:887–894
16. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proceedings of the National Academy of Sciences of the United States of America. 1998;17:9991–9996
17. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, et al. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Archives of General Psychiatry. 1989;11:1012–1016
18. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry. 1989;11:1006–1011
19. Gothelf D, Presburger G, Zohar AH, Burg M, Nahmani A, Frydman M, et al. Obsessive–compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome. American Journal of Medical Genetics. 2004;1:99–105
20. Huotari M, Gogos JA, Karayiorgou M, Koponen O, Forsberg M, Raasmaja A, et al. Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice. European Journal of Neuroscience. 2002;2:246–256
21. Jiang H, Xie T, Ramsden DB, Ho SL. Human catechol-O-methyltransferase down-regulation by estradiol. Neuropharmacology. 2003;7:1011–1018
22. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive–compulsive disorder. Proceedings of the National Academy of Sciences of the United States of America. 1997;9:4572–4575
23. Karayiorgou M, Sobin C, Blundell ML, Galke BL, Malinova L, Goldberg P, et al. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive–compulsive disorder. Biological Psychiatry. 1999;9:1178–1189
24. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 1987;2:261–276
25. Keating GM, Lyseng-Williamson KA. Tolcapone: a review of its use in the management of Parkinson's disease. Central Nervous System Drugs. 2005;2:165–184
26. McGrath M, Kawachi I, Ascherio A, Colditz GA, Hunter DJ, De VI. Association between catechol-O-methyltransferase and phobic anxiety. American Journal of Psychiatry. 2004;9:1703–1705
27. McIntosh AM, Baig BJ, Hall J, Job D, Whalley HC, Lymer GK, et al. Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis. Biological Psychiatry. 2007;61:1127–1134
    • Abstract
    • Full Text
    • Full-Text PDF (3656 KB)
28. Meira-Lima I, Shavitt RG, Miguita K, Ikenaga E, Miguel EC, Vallada H. Association analysis of the catechol-O-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive–compulsive disorder. Genes, Brain and Behavior. 2004;2:75–79
29. Morey RA, Inan S, Mitchell TV, Perkins DO, Lieberman JA, Belger A. Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. Archives of General Psychiatry. 2005;3:254–262
30. Morilak DA, Barrera G, Echevarria DJ, Garcia AS, Hernandez A, Ma S, et al. Role of brain norepinephrine in the behavioral response to stress. Progress in Neuropsychopharmacology and Biological Psychiatry. 2005;8:1214–1224
31. Morrison D, Clark D, Goldfarb E, McCoy L. Worsening of obsessive–compulsive symptoms following treatment with olanzapine. American Journal of Psychiatry. 1998;6:855
32. Mottard JP, de la Sablonniere JF. Olanzapine-induced obsessive–compulsive disorder. American Journal of Psychiatry. 1999;5:799–800
33. Muller T, Erdmann C, Muhlack S, Bremen D, Przuntek H, Woitalla D. Inhibition of catechol-O-methyltransferase contributes to more stable levodopa plasma levels. Movement Disorders. 2006;3:332–336
34. Munafo MR, Bowes L, Clark TG, Flint J. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Molecular Psychiatry. 2005;8:765–770
35. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Archives of General Psychiatry. 1999;10:940–945
36. Nechmad A, Ratzoni G, Poyurovsky M, Meged S, Avidan G, Fuchs C, et al. Obsessive–compulsive disorder in adolescent schizophrenia patients. American Journal of Psychiatry. 2003;5:1002–1004
37. Niehaus DJ, Kinnear CJ, Corfield VA, du Toit PL, van Kradenburg J, Moolman-Smook JC, et al. Association between a catechol-O-methyltransferase polymorphism and obsessive–compulsive disorder in the Afrikaner population. Journal of Affective Disorders. 2001;1:61–65
38. Ongur D, Goff DC. Obsessive–compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status. Schizophrenia Research. 2005;2–3:349–362
39. Palmatier MA, Kang AM, Kidd KK. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biological Psychiatry. 1999;4:557–567
40. Poyurovsky M, Fuchs C, Weizman A. Obsessive–compulsive disorder in patients with first-episode schizophrenia. American Journal of Psychiatry. 1999;12:1998–2000
41. Pujol J, Soriano-Mas C, Alonso P, Cardoner N, Menchon JM, Deus J, et al. Mapping structural brain alterations in obsessive–compulsive disorder. Archives of General Psychiatry. 2004;7:720–730
42. Rothe C, Koszycki D, Bradwejn J, King N, Deluca V, Tharmalingam S, et al. Association of the Val158Met catechol-O-methyltransferase genetic polymorphism with panic disorder. Neuropsychopharmacology. 2006;10:2237–2242
43. Sauer S, Gut IG. Genotyping single-nucleotide polymorphisms by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry. Journal of Chromatography B: Analytical Technological Biomedical Life Sciences. 2002;1–2:73–87
44. Schindler KM, Richter MA, Kennedy JL, Pato MT, Pato CN. Association between homozygosity at the COMT gene locus and obsessive compulsive disorder. American Journal of Medical Genetics. 2000;6:721–724
45. Tunbridge EM, Harrison PJ, Weinberger DR. Catechol-O-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biological Psychiatry. 2006;2:141–151
    • MEDLINE
46. van den Heuvel OA, Veltman DJ, Groenewegen HJ, Cath DC, van Balkom AJ, van Hartskamp J, et al. Frontal-striatal dysfunction during planning in obsessive–compulsive disorder. Archives of General Psychiatry. 2005;3:301–309
47. van der Wee NJ, Stevens H, Hardeman JA, Mandl RC, Denys DA, van Megen HJ, et al. Enhanced dopamine transporter density in psychotropic-naive patients with obsessive–compulsive disorder shown by [¹²³I]{beta}-CIT SPECT. American Journal of Psychiatry. 2004;12:2201–2206
48. Wahlstrom D, White T, Hooper CJ, Vrshek-Schallhorn S, Oetting WS, Brott MJ, et al. Variations in the catechol-O-methyltransferase polymorphism and prefrontally guided behaviors in adolescents. Biological Psychiatry. 2007;61:626–632
    • Abstract
    • Full Text
    • Full-Text PDF (158 KB)
49. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, et al. Prefrontal neurons and the genetics of schizophrenia. Biological Psychiatry. 2001;11:825–844